Title : Aβ-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer's disease via enhancing microglial Aβ clearance.

Pub. Date : 2022 Apr

PMID : 35286856






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Abeta-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer"s disease via enhancing microglial Abeta clearance. Metformin amyloid beta precursor protein Homo sapiens
2 Abeta-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer"s disease via enhancing microglial Abeta clearance. Metformin amyloid beta precursor protein Homo sapiens
3 Here, inspired by the concept of supramolecular inclusion complex, we successfully fabricate metformin (Met)-based supramolecular nanodrugs with the Abeta-responsive on-demand drug release for synergistic Alzheimer"s disease (AD) therapy via enhancing microglial Abeta clearance. Metformin amyloid beta precursor protein Homo sapiens
4 Here, inspired by the concept of supramolecular inclusion complex, we successfully fabricate metformin (Met)-based supramolecular nanodrugs with the Abeta-responsive on-demand drug release for synergistic Alzheimer"s disease (AD) therapy via enhancing microglial Abeta clearance. Metformin amyloid beta precursor protein Homo sapiens